Description
Cell line name NCC-UPS3-C1
Accession CVCL_B3RN
Resource Identification Initiative To cite this cell line use: NCC-UPS3-C1 (RRID:CVCL_B3RN)
Comments Part of: NCC sarcoma cell line panel.
Population: Japanese.
Doubling time: 61.6 hours (PubMed=34665443).
Omics: SNP array analysis.
Derived from site: Metastatic; Left buttock, hypodermis; UBERON=UBERON_0013691+UBERON_0002072.
Sequence variations
Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Unspecified (PubMed=34665443).
Gene deletion; HGNC; 1788; CDKN2B; Zygosity=Unspecified (PubMed=34665443).
Disease Undifferentiated pleomorphic sarcoma (NCIt: C4247)
Undifferentiated pleomorphic sarcoma (ORDO: Orphanet_2023)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Female
Age at sampling 55Y
Category Cancer cell line
STR profile
Source(s): PubMed=34665443
Markers:
Amelogenin | X |
CSF1PO | 10,11,12 |
D5S818 | 11,12,13 |
D7S820 | 10,11 |
D13S317 | 10,12 |
D16S539 | 9,10 |
D21S11 | 29,31 |
TH01 | 9,9.3 |
TPOX | 11 |
vWA | 17,20,21,22 |
Publications
PubMed=34665443; DOI=10.1007/s13577-021-00633-w
Tsuchiya R., Yoshimatsu Y., Noguchi R., Sin Y., Ono T., Akiyama T., Sugaya J., Nakatani F., Kojima N., Yoshida A., Ohtori S., Kawai A., Kondo T.
Establishment and characterization of NCC-UPS3-C1: a novel patient-derived cell line of undifferentiated pleomorphic sarcoma.
Hum. Cell 35:384-391(2022)
Cross-references
Encyclopedic resources Wikidata; Q110433091
Reviews
There are no reviews yet.